pages. This page limitation shall apply regardless of the number of issues raised in the ADR proceeding. Within eleven (11) days following completion of the hearing, each party may submit to the other party and the neutral a post-hearing rebuttal brief, responding to the matters raised in the other party's post hearing brief, provided that such rebuttal brief shall only respond to matters raised in the other party's post-hearing brief, shall not contain or discuss any new evidence, and shall not exceed five (5) pages.
Appears in 2 contracts
Sources: International License Agreement (Sonus Pharmaceuticals Inc), International License Agreement (Sonus Pharmaceuticals Inc)
pages. This page limitation shall apply regardless of the number of issues raised in the ADR proceeding. Within eleven fourteen (1114) days following completion of the hearing, each party Party may submit to the other party Party and the neutral a post-hearing rebuttal brief, responding to the matters raised in the other partyParty's post post-hearing brief, provided that such rebuttal brief shall only respond to matters raised in the other partyParty's post-hearing brief, shall not contain or discuss any new evidence, and shall not exceed five (5) pages.
Appears in 1 contract
Sources: Collaborative Research and License Agreement (Axys Pharmecueticals Inc)